Key Takeaways SYNCHRONICITY met both co-primary endpoints at 6 months, with improvements in BCVA and CST maintained through ...

Key Takeaways STK-002 is an investigational RNA-based therapy designed to increase OPA1 protein expression in patients with autosomal dominan ...

Brent Saunders, who returned to Bausch + Lomb in 2023 for his second stint as CEO, announced his departure on Monday. ...

Key Takeaways Moorfields Private has introduced specialist eye assessments for patients taking GLP-1 medications, including ...

Key Takeaways Two AAO case reports examine cryopreserved amniotic membrane in neurotrophic keratitis and severe HSV keratitis ...

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.

Both Zenkuda and tabirafusp-ted met the phase 3 DAYBREAK primary endpoints, achieving noninferiority to aflibercept for vision gains at 1 year in patients with wet AMD Kodiak reported that 54% of ...

MyEyeDr. has agreed to acquire EyeCare Partners' optometry division, including more than 300 offices across 5 eye care brands MyEyeDr. said the expanded organization will support greater access to ...

B+L Advances Two Ophthalmic Pipeline Therapies in DED and Ocular Surface Pain ...